MEDICIS TECHNOLOGIES CORPORATION | Bausch Health | Washington | state | 2004 | undisclosed | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $333,589 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $263,847 | | tax credit/rebate |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $168,442 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $85,688 | | tax credit/rebate |
NOVARTIS VACCINES & DIAGNOSTICS INC | Novartis | Washington | state | 2004 | $27,300 | | tax credit/rebate |
ILLUMIGEN BIOSCIENCES INC | Merck | Washington | state | 2004 | $11,367 | | tax credit/rebate |
Merck & Co., Inc. | Merck | North Carolina | state | 2004 | $24,000,000 | | grant/loan hybrid program |
Novartis Animal Health US Inc. | Novartis | Iowa | state | 2004 | $191,891 | | training reimbursement |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
Endo Pharmaceuticals Valera, Inc. | Endo International | New Jersey | state | 2004 | $86,295 | | grant |
Chugai Pharma USA | Roche | New Jersey | state | 2004 | $582,225 | | grant |
Dava Pharmaceuticals, Inc. | Endo International | New Jersey | state | 2004 | $931,560 | | grant |
Daiichi Sankyo, Inc. | Daiichi Sankyo | New Jersey | state | 2004 | $1,330,304 | | grant |
Novartis Pharmaceuticals Corporation ("NPC") | Novartis | New Jersey | state | 2004 | $5,822,250 | | grant |
Celgene Corporation | Bristol-Myers Squibb | New Jersey | state | 2004 | $6,086,250 | | grant |
Abbott Laboratories, Ross Products Div | Abbott Laboratories | Arizona | state | 2004 | $235,647 | | training reimbursement |
GLAXOSMITHKLINE BIOLOGICALS NORTH AMERICA | GlaxoSmithKline | Washington | state | 2004 | $253,000 | | tax credit/rebate |
I C O S CORP | Eli Lilly | Washington | state | 2004 | $22,005 | | tax credit/rebate |
IMMUNEX CORPORATION | Amgen | Washington | state | 2004 | $581,065 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
ZYMOGENETICS INC | Bristol-Myers Squibb | Washington | state | 2004 | $481,822 | | tax credit/rebate |
Wyeth-Lederle (#2) | Pfizer | North Carolina | state | 2004 | $500,000 | | grant |
MedImmune, Inc. | AstraZeneca | Maryland | state | 2004 | $26,775 | | training reimbursement |
Shire US Manufacturing, Inc. | Takeda Pharmaceutical | Maryland | state | 2004 | $26,595 | | training reimbursement |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2004 | $588,423 | | tax credit/rebate |
Medimmune, Inc. | AstraZeneca | Maryland | state | 2004 | $294,900 | | tax credit/rebate |
Medimmune Oncology, Inc. | AstraZeneca | Maryland | state | 2004 | $103,579 | | tax credit/rebate |
Amgen Inc. | Amgen | Maryland | state | 2004 | $88,478 | | tax credit/rebate |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2004 | $50,128 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2004 | $47,393 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2004 | $34,995 | | tax credit/rebate |
Pfizer Inc. | Pfizer | Maryland | state | 2004 | $33,734 | | tax credit/rebate |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2004 | $29,577 | | tax credit/rebate |
Macrogenics, Inc. | MacroGenics | Maryland | state | 2004 | $25,397 | | tax credit/rebate |
Cambrex Corporation | Cambrex | Maryland | state | 2004 | $19,690 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2004 | $3,426 | | tax credit/rebate |
Serono, Inc. | Merck KGaA (EMD) | Maryland | state | 2004 | $2,732 | | tax credit/rebate |
Pharmacia Corporation | Pfizer | Maryland | state | 2004 | $1,884 | | tax credit/rebate |
PharmaForce, Inc. | Daiichi Sankyo | Ohio | state | 2004 | undisclosed | | tax credit/rebate |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2004 | undisclosed | | property tax abatement |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2004 | $17,000 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2004 | $653,700 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2004 | $1,130,588 | | enterprise zone |
Parke, Davis & Company | Pfizer | Michigan | state | 2004 | undisclosed | | property tax abatement |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
NEUTROGENA CORPORATION | Johnson & Johnson | California | state | 2003 | $202,588 | | training reimbursement |
PHARMACIA & UPJOHN COMPANY | Pfizer | Michigan | local | 2003 | undisclosed | | property tax abatement |
L PERRIGO CO | Perrigo | Michigan | local | 2003 | undisclosed | | property tax abatement |
Doral/Pfizer | Pfizer | New York | local | 2003 | $613,020 | | tax credit/rebate; property tax abatement |
Bristol Myers Squibb (Mr. Leon Squibb) | Bristol-Myers Squibb | New York | local | 2003 | $343,428 | | tax credit/rebate; property tax abatement |
Bausch & Lomb | Bausch Health | New York | local | 2003 | $266,156 | | tax credit/rebate; property tax abatement |
Johnson & Johnson | Johnson & Johnson | New York | local | 2003 | $167,430 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $61,743 | | tax credit/rebate; property tax abatement |
Regeneron II(Mill Road) | Regeneron Pharmaceuticals | New York | local | 2003 | $46,350 | | tax credit/rebate; property tax abatement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2003 | $31,580 | | tax credit/rebate; property tax abatement |
Valmed Pharamaceutical, Inc. | AbbVie | New York | local | 2003 | $4,607 | | tax credit/rebate; property tax abatement |
Mylan Technologies, Inc. | Viatris | Vermont | state | 2003 | $2,426,152 | | tax credit/rebate; property tax abatement |
Intervet | Merck | Delaware | state | 2003 | $19,925 | | training reimbursement |
Pfizer | Pfizer | New York | local | 2003 | $10,401,000 | | tax credit/rebate; property tax abatement |
Andrx Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | Florida | state | 2003 | undisclosed | | tax credit/rebate |
Taro Pharmaceuticals U.S.A., Inc. | Sun Pharmaceuticals | New Jersey | state | 2003 | $1,287,195 | | grant |
Valeant Pharmaceuticals North America LLC and | Bausch Health | New Jersey | state | 2003 | $4,325,100 | | grant |
NPS Pharmaceuticals, Inc. | Takeda Pharmaceutical | New Jersey | state | 2003 | $4,371,200 | | grant |
Ventana Medical Systems | Roche | Arizona | state | 2003 | $585,765 | | training reimbursement |
Aldrich Chemical | Merck KGaA (EMD) | Wisconsin | state | 2003 | $2,426,984 | | tax increment financing |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $65,000 | | grant |
Embrex, Inc. | Pfizer | North Carolina | state | 2003 | $9,228 | | grant |
Abbott Laboratories | Abbott Laboratories | North Carolina | state | 2003 | $50,000 | | grant |
ETHICON, INC. | Johnson & Johnson | Texas | state | 2003 | undisclosed | | enterprise zone |
L. Perrigo Company | Perrigo | Michigan | local | 2003 | undisclosed | | property tax abatement |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $8,249 | | enterprise zone |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2003 | $5,679,250 | | enterprise zone |
Clay-Park Labs, Inc. | Perrigo | New York | state | 2003 | $257,000 | | enterprise zone |
Pfizer, Inc. | Pfizer | New York | state | 2003 | $2,956,000 | | enterprise zone |
Regeneron Pharmacueticals, Inc. | Regeneron Pharmaceuticals | New York | state | 2003 | $4,885,774 | | enterprise zone |
SYNTHES (U.S.A.) | Johnson & Johnson | New York | state | 2003 | $939,077 | | enterprise zone |
Pharmacia & Upjohn Company | Pfizer | Michigan | state | 2003 | undisclosed | | property tax abatement |
WARNER-LAMBERT COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
PHARMACIA & UPJOHN COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
PARKE DAVIS & COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
PHARMACIA & UPJOHN COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
PHARMACIA & UPJOHN COMPANY | Pfizer | Michigan | local | 2002 | undisclosed | | property tax abatement |
CORIUM INTERNATIONAL INC | Corium International | Michigan | local | 2002 | undisclosed | | property tax abatement |
CORIUM INTERNATIONAL INC | Corium International | Michigan | local | 2002 | undisclosed | | property tax abatement |
PERRIGO RESEARCH & DEVELOPMENT COMPANY | Perrigo | Michigan | local | 2002 | undisclosed | | property tax abatement |
PHARMACIA CORPORATION | Pfizer | Missouri | state | 2002 | $3,235,374 | | tax credit/rebate |
G.D. SEARLE & COMPANY | Pfizer | Missouri | state | 2002 | $1,126,728 | | tax credit/rebate |
ELI LILLY & COMPANY | Eli Lilly | Missouri | state | 2002 | $130,344 | | tax credit/rebate |
C3I,Incorporated | Merck | New York | local | 2002 | $50,592 | | grant |
Abbott Bioresearch Center, inc. | Abbott Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
IDEXX Veterinary Services | IDEXX Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2002 | $1,866,487 | | grant |
Barr Laboratories, Inc. and Subsidiaries | Teva Pharmaceutical Industries | New Jersey | state | 2002 | $1,969,200 | | grant |